Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Cancer cells can bind to T-cells and “turn-off” their ability to detect and kill tumor cells. Immunotherapy drugs bind to T-cells and keep them “on” by ...
A preliminary analysis of a 25-patient Phase 1/2 study evaluating Advaxis' (ADXS +12.7%) lead immunotherapy candidate, ADXS-HPV, showed that ...
With no major advances in survival in bladder cancer in more than 30 years, interest is high in the potential to deploy immunotherapeutic approaches ...
... presented an overview of research into immunotherapy strategies in RCC during the 8th Annual Interdisciplinary Prostate Cancer Congress in New ...
He began with a basic explanation of the history of immunotherapy and how because cancer commonly grows from our cells, the immune system often ...
This creates a natural target for immunotherapy -- therapy that harnesses the power of a patient's own immune system to help destroy cancer cells.
The deadly disease remains the fifth leading cause of cancer-related ... Their warning signals are amplified by the immune system, making them ...
Colon cancer is the second most common form of cancer death in the ... Vitamin D has been shown to boost the immune system's defense against ...
"The 8th Element: Nature's Universal Cancer Killer." Inside your special report, you'll find specific 8th Element therapies you can implement right now, safely from home, for pennies on the dollar - without dangerous side effects ... and even if you don't have health insurance or a prescription. Order your special report that details how our beloved 40th President beat cancer by bucking the system and following his own path. [I am not endorsing this, just letting you know of it]
TAIPEI -- A Taiwanese research team has developed an antibody to block a protein that is associated with metastasis of pancreatic cancer to other ...
OncoSil Medical (ASX:OSL) has added liver cancer to its development platform to treat pancreatic cancer after the clinical data set demonstrates that ...
Throat, esophagus, colon and breast cancer have all been linked to alcoholism. It' ;s possible, but not definitive, that pancreatic cancer is also linked to ...
The risk for kidney cancer was 4 times higher and bladder cancer was 1.5 times higher. “These results suggest that patients with ESRD are uniquely at ...
The 25-year Canadian National Breast Screening Study followed 89,835 women, aged 40 to 59, in a randomized controlled trial. About half of the women were given annual mammograms and the other half just visited their doctor without receiving the test. The researchers found that getting an annual mammogram does not reduce the mortality from breast cancer any more than getting a physical exam from a doctor. They also found that annual mammograms are not just useless; they can be seriously harmful. The study results showed a significant risk of over-diagnosis and over-treatment
Fit blackout blinds and ban gadgets to avert disease, say experts
Cutting out light sources halt interruptions to body clocks, say experts
Learning to love the dark means prevents changes to our internal rhythm
The change has been linked to health problems as cancer and diabetes
Science Daily Cancer News
Predicting prostate cancer: Nanotechnology shows promise for more accurate prostate cancer screening and prognosis
A study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments. The prostate-specific antigen (PSA) test was once the recommended screening tool for detecting prostate cancer, but there is now disagreement over the use of this test because it can't predict which men with elevated PSA levels will actually develop an aggressive form of the disease.
Colon cancer is a heavily studied disease -- and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on the rise, from 500,00 deaths in 1990 to 700,000 in 2010. This growth comes despite scientists' ever-increasing knowledge of the genetic mutations that initiate and drive this disease. Now, a team of researchers has found evidence of a new culprit in the disease, a protein called MSI2.
Cells have two different programs to safeguard them from developing cancer. One of them is senescence. It puts cancer cells into a permanent sleep. Now researchers have discovered that an enzyme known to be active in breast cancer blocks this protection program and boosts tumor growth. They succeeded in blocking this enzyme in mice with breast cancer, thus reactivating senescence and stopping tumor growth.
Cancer cells crowded tightly together suddenly surrender their desire to spread, and this change of heart is related to a cellular pathway that controls organ size, scientists have found. "What we really need in cancer treatment is a way to stop cancer from growing in the organ it has spread to, and we have discovered a mechanism that seems to do that," says the study's senior investigator.
Of prostate cancer patients with combination MAP3K7 and CHD1 deletions, about 50 percent will have recurrent prostate cancer, which ultimately leads to death, a study concludes. About 10 percent of all prostate cancers harbor combined MAP3K7-CHD1 deletions.
Researchers conducted a study that looked at how proteasome-specific chaperones work at the molecular level to help in proteasome formation. Fully understanding this process may present new target sites for drugs and may lead to better treatments for neurological diseases, cancers and other disorders.
Increasingly high prices for cancer drugs are affecting patient care in the U.S. and the American health care system overall, say researchers. "Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries," says one of the authors. "As oncologists we have a moral obligation to advocate for affordable cancer drugs for our patients."
Tambahkan Komentar